Rankings
▼
Calendar
INDV FY 2016 Earnings — Indivior Pharmaceuticals Inc Revenue & Financial Results | Market Cap Arena
INDV
Indivior Pharmaceuticals Inc
$4B
FY 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$969M
Gross Profit
$858M
88.6% margin
Operating Income
$338M
34.9% margin
Net Income
$32M
3.3% margin
EPS (Diluted)
$0.22
Cash Flow
Operating Cash Flow
$373M
Free Cash Flow
$341M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$1.5B
Stockholders' Equity
-$295M
Cash & Equivalents
$692M
← FY 2017
All Quarters
